12 Results

People

  1. Zelefsky
    Zelefsky
  2. Fearn
    Fearn
  3. Calugaru
    Calugaru
  4. Ho
    Ho
  5. Kantoff
    Kantoff
  6. Kollmeier
    Kollmeier
  7. McBride
    McBride
  8. Pei
    Pei
  9. Zhang
    Zhang
  10. Afaq
    Afaq

Groups

  1. Survivorship Research (5)
  2. Biostatistics Service (3)
  3. Epidemiology and Biostatistics (3)
  4. GDMT, Radiation Oncology (3)
  5. Gynecology Disease Management Team (3)
  6. Radiation Oncology, Department of (3)
  7. Department of Medicine (2)
  8. Genitourinary Oncology Service (2)
  9. Sloan Kettering Institute Postdocs (2)
  10. Solid Tumor Oncology Division (2)
  1. "biochemical failure"
Formats
  1. Journal Article (12)
Groups
  1. Survivorship Research (5)
  2. Biostatistics Service (3)
  3. Epidemiology and Biostatistics (3)
  4. GDMT, Radiation Oncology (3)
  5. Gynecology Disease Management Team (3)
  6. Radiation Oncology, Department of (3)

More Groups

People
  1. Michael Zelefsky (5)
  2. Marisa Kollmeier (3)
  3. Paul Fearn (3)
  4. Alice Ho (2)
  5. Emel Calugaru (2)
  6. Philip Kantoff (2)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2015 (1)
  5. 2012 (1)
  6. 2010 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (6)
  2. Cancer (2)
  3. Journal of Urology (2)
  4. BJU International (1)
  5. European Urology (1)
Publishers
  1. Elsevier Inc. (6)
  2. Elsevier Science, Inc. (3)
  3. Wiley Blackwell (3)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer–specific mortality
    Journal Article

    Bitterman, D. S.; Chen, M. H.; Wu, J.; Renshaw, A. A.; Loffredo, M.; Kantoff, P. W.; Small, E. J.; D'Amico, A. V.
    Cancer (2021)

    Fulltext@MSK | Save
  • Low-dose-rate brachytherapy combined with ultrahypofractionated radiation therapy for clinically localized, intermediate-risk prostate cancer: Results from a prospective trial
    Journal Article

    Kollmeier, M. A.; McBride, S.; Varghese, M.; Debonis, D.; Zhang, Z.; Cohen, G.; Damato, A. L.; Mychalczak, B.; Gewanter, R.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials
    Journal Article

    Atkins, K. M.; Chen, M. H.; Wu, J.; Renshaw, A. A.; Loffredo, M.; Kantoff, P. W.; Small, E. J.; D'Amico, A. V.
    Cancer (2018)

    Fulltext@MSK | Save
  • The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Romesser, P. B.; Pei, X.; Zhang, Z. G.; Polkinghorn, W.; McBride, S.; Kollmeier, M.; Yamada, Y.; Zelefsky, M. J.
    European Urology (2015)

    Fulltext@MSK | Save
  • Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy
    Journal Article

    Riaz, N.; Afaq, A.; Akin, O.; Pei, X.; Kollmeier, M. A.; Cox, B.; Hricak, H.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer
    Journal Article

    Burri, R. J.; Ho, A. Y.; Forsythe, K.; Cesaretti, J. A.; Stone, N. N.; Stock, R. G.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy
    Journal Article

    Ho, A. Y.; Burri, R. J.; Cesaretti, J. A.; Stone, N. N.; Stock, R. G.
    International Journal of Radiation Oncology, Biology, Physics (2009)

    Fulltext@MSK | Save
  • High-intensity focused ultrasound for prostate cancer: Comparative definitions of biochemical failure
    Journal Article

    Blana, A.; Brown, S. C. W.; Chaussy, C.; Conti, G. N.; Eastham, J. A.; Ganzer, R.; Murat, F. J.; Pasticier, G.; Rebillard, X.; Rewcastle, J. C.; more...
    BJU International (2009)

    Fulltext@MSK | Save
  • 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer (Reprinted from The Journal of Urology, vol 173, pg 1562-1566, 2005)
    Journal Article

    Potters, L.; Morgenstern, C.; Calugaru, E.; Fearn, P.; Jassal, A.; Presser, J.; Mullen, E.
    Journal of Urology (2008)

    Fulltext@MSK | Save
  • Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer
    Journal Article

    Zelefsky, M. J.; Ben-Porat, L.; Chan, H. M.; Fearn, P. A.; Venkatraman, E. S.
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save